VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES
- Status
- UNKNOWN
- Phase
- PHASE1
PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAA
- Status
- UNKNOWN
- Phase
- NA
A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1